A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
Clinical trial NCT00612170 · COMPLETED
Trial details
- NCT number
- NCT00612170
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2009-05-01
- Enrollment
- 1129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.